ÂÜÀòÂÒÂ×

Dee Mahoney is the Founder and Principal of DLM Biotech Consulting, offering high-level strategic consultation to the biotechnology and life sciences sectors since June 2021. Currently, Dee leads strategy at Sonder Research X and serves as a Senior Business and Commercial Advisor at MycRx, along with advisory roles at PDX Pharmaceuticals and Pattern Pharma. Previous experience includes serving as Senior Vice President and Chief Commercial Officer at Sumitomo Dainippon Pharma Oncology, where infrastructure for the first product launch was established, and as a key executive at Pfizer, where leadership included building commercial infrastructure for the Specialty Products Business Unit and managing significant sales divisions. Dee's educational background includes studies at The Wharton School, Harvard Business School, and a BS in Organic Chemistry and Microbiology from Stephen F. Austin State University.